Latest Videos |view all videos
Edward V. Loftus Jr., M.D., discusses some of the issues surrounding this medication, and its potential benefits and drawbacks.
The FDA recently approved a biosimilar (CT-P13) to infliximab, which is used for treating people with IBD, as well as people with rheumatoid arthritis ankylosing spondylitis, psoriatic arthritis and plaque psoriasis.
Aleksey Matveyenko, Ph.D., presents Role of Circadian System in Regulation of Insulin Secretion: Implications for Diabetes Prevention and Treatment.
Rozalina G. McCoy, M.D., presents Evaluation of Diabetes Care Quality and Value: Role of Optum Labs in Patient-Centered Health Care Delivery Research.
Michael F. Picco, M.D., Ph.D., and Michael B. Wallace, M.D., gastroenterologists at Mayo Clinic's campus in Jacksonville, Florida, demonstrate a simplified technique for application of indicarmine and other staining agents for surveillance ...
Maria I. Vazquez Roque, M.D., discusses non-celiac gluten sensitivity (NCGS).